AI assistant
Sending…
ProPhase Labs, Inc. — Director's Dealing 2024
Mar 20, 2024
34999_dirs_2024-03-19_a61a5d0e-b35e-4ddf-b1d1-f2a76b285f92.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2024-01-01
Reporting Person: Latkin Jed (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-01-01 | Option (right to buy) | $6.00 | A | 500000 | Acquired | 2031-01-01 | Common Stock (500000) | Direct |
Footnotes
F1: The option vests over a three year period, with 25% vesting on the date of grant and 25% vesting on each anniversary thereafter, subject to the Reporting Person's continued service through each vesting date
More from ProPhase Labs, Inc.
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Feb 13
Regulatory Filings
2026
Feb 13
Regulatory Filings
2026
Jan 27
Regulatory Filings
2026
Jan 23
Delisting Announcement
2026
Jan 23
Regulatory Filings
2026
Jan 23
Regulatory Filings
2026
Jan 9
Regulatory Filings
2026
Jan 9
Regulatory Filings
2026
Jan 2